Organization and Administration

ICMIC（g斯坦福大学）已经从最初于2000年资助的P20（随后于2004年资助ICMIC PSO）发展成为一个多学科计划，该计划具有支持多模态分子成像领域的专业知识和基础设施。Gambhir博士是ICMIC的PI，他有意识地努力将他对放射学和分子药理学的兴趣融合在一起，专注于迅速兴起的分子成像领域。 早些时候，Gambhir博士是UCLA-ICMIC的关键贡献者，他的实验室非常胜任地提供了基础癌症生物学家和生物医学成像科学家之间的理想联系。2003年7月，Gambhir博士带着他的20名学生/博士后实验室搬到了斯坦福大学。Contag博士是ICMIC的合作伙伴，他职业生涯的很大一部分时间都专注于小动物生物发光光学成像，并帮助这项技术在斯坦福大学校园内外广泛应用。Gambhir博士和Contag博士一起提供了从基础科学到临床前成像再到分子成像临床应用的巨大广度。此外，他们也都有一个主要重点是癌症的研究，并都致力于分子成像的临床翻译。

The ICMIC(gStanford has matured from a P20 initially funded in 2000, with subsequent funding of the ICMIC PSO in 2004, to a multidisciplinary program with the expertise and infrastructure to support the growing field of multimodality molecular imaging. Dr Gambhir, the ICMIC PI, has made a conscious effort to merge his interests in radiology and molecular pharmacology to focus on the rapidly emerging field of molecular imaging. Eariier on, Dr. Gambhir was a key contributor to the UCLA-ICMIC where his lab very competently provided the ideal link between basic cancer biologists and biomedical imaging scientists. Dr. Gambhir then moved to Stanford with his lab of 20 students/postdocs in July 2003. ICMIC Co-PI, Dr. Contag, has spent a significant portion of his career focused on small animal bioluminescence optical imaging and has helped to make this technology widely available on the Stanford Campus and beyond. Together Drs. Gambhir and Contag provide an enormous breadth spanning from basic science, to pre-clinical imaging, to clinical applications of molecular imaging. Additionally, they both also have a primary emphasis on the study of cancer, and are both committed to clinical translation of molecular imaging.